|

Chemotherapy Regimen 1 Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since July 2026

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Pfizer2
  • Biotheus Inc.1

Indications

  • Cancer3
  • Carcinoma, Non-Small-Cell Lung (NSCLC)2
  • Lung Cancer2
  • Non Small Cell Lung Cancer2
  • Non-Small Cell Lung Cancer Non-squamous1

Other1 trial

PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
Phase 2

Huntsville, Alabama1 trial

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Clearview Cancer Institute (Crestwood)

Phase 2

Bullhead City, Arizona1 trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Pioneer Research Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.